Susan u can start by buying a little first

susan, i like ur name

GI resources sdn Bhd may be linked to Kanger, it's a collaboration...
Third party investor must be a proxy

Buy q more than 400k lots at 0.17
weird, I guess we will find out soon

GI resources may be the interested 3rd party for PP......

0.17 is the strongest support ever for this counter Right Now.

im really wondering who r these 3rd party
if anyone gets info pls post here

Lol

Lol.

Malaysia has Logistics for -70 Degrees vaccine, but storage in clinics? It extremely difficult.

I had to Interfere
a Government cannot Buy Directly a merchandise or any products from another country.
You will need a Company
simple, can China buy Petroleum directly from Malaysia
U need Petronas, or a company which hold a certain Exclusivity Rights

The reason why -70 is a big deal because china vaccine is in the log book.

Hero76, Yes. In normal scenarios.
This time its different. Once vaccine is out, it going to be fireworks
How fast from this price to 0.90 is as fast as 3 days

I dreamed Monday price open at 26.5 cents ooooo, phewww

My TP is rm5

20% PP, so price will drop 20%
I personally feels support is at 0.20
So correction is heading towards 0.16... Whatever above 0.16 is higher than correction price, once PP is completed it will rise as per vaccine news

Just let the PP complete, Kura kura will turn into NInja Turtle

pheww added more at 0.17
Puas

Npra how many shares u holding

https://www.klsescreener.com/v2/news/view/752769

any idea who will be the 3rd party Investor?

we r facing a tough time due to this
All will be ok.

Private Placement and Share Price
If the entity conducting a private placement is a private company, the private placement offering has no effect on share price because there are no pre-existing shares.

With a publicly-traded company, the percentage of equity ownership that existing shareholders have prior to the private placement is diluted by the secondary issuance of additional stock, since this increases the total number of shares outstanding. The extent of the dilution is proportionate to the size of the private placement offering.

For example, if there were 1 million shares of a company's stock outstanding prior to a private placement offering of 100,000 shares, then the private placement would result in existing shareholders having 10 percent less of an equity interest in the company. However, if the company offered an additional 1 million shares through the private placement, that would reduce the ownership percentage of existing shareholders by 50 percent.

Npra how much u holding?

Hehe when this shoots, we should all get together for a yam cha

It's not just kanger it's on all vaccine related counters
It's called profit taking

GoUpUp KStar is really something. It still continues to go uptrend.

But I am pretty sure that will happen to Kanger once the price hold is removed following the completion of the PP.
10/11/2020 12:03 PM

This is exactly whats gonna happen

Bowman, SinoPharm has 2 vaccine candidates...

expect major news in the next 2 weeks!

Pang , u r so right
its Pfizer, SinoPharm, Cansino
Remember SinoPharm has 2 vaccine candidates
its a huge market!!!

The recepient of the private placement could be a punter and push the share up or he may be a genuine investor pumping money into the company to improve cash flow or investment.

Hence , i hope everyone understands whats happening here...

private placement is extremely good for a company

Not related to the vaccine

Sao Paulo’s Instituto Butantan, which partnered with Sinovac to produce the vaccine locally, said in a statement it was surprised by the decision and is looking into details of what happened in the study. Director Dimas Covas said in a TV interview that one volunteer in the trial has died, but that the death is not related to the vaccine.

Sinovac’s company representative did not immediately respond to a request for comment.

Halts to investigate serious adverse events are not uncommon in large-scale drug trials and two western developers - AstraZeneca Plc and Johnson & Johnson -- have paused their vaccine trials in recent months due to such incidents, only to re-start them after investigation.

Not related to the vaccine.

Sao Paulo’s Instituto Butantan, which partnered with Sinovac to produce the vaccine locally, said in a statement it was surprised by the decision and is looking into details of what happened in the study. Director Dimas Covas said in a TV interview that one volunteer in the trial has died, but that the death is not related to the vaccine.

Sinovac’s company representative did not immediately respond to a request for comment.

Halts to investigate serious adverse events are not uncommon in large-scale drug trials and two western developers - AstraZeneca Plc and Johnson & Johnson -- have paused their vaccine trials in recent months due to such incidents, only to re-start them after investigation.

Pfizer on a highlight and suddenly china vaccine gets a boo.....
:)

Guys , CoronaVac is not same as Sinopharm.... :)

Guys u will hears news, remember CoronaVac is not same as Cansino or Sinopharm

NPRA , good its down.. hehe just stay back and enjoy..

if*

Imagine if the news was Sinopharm vaccine approved!!

Imagine is the news was Cansino vaccine approved!!!

too many petty traders.... buy sell so quickly

Hold on Guys...

Guys just hold ....

anyway , it says 90% ready... LoL MEANS THEY R NOT

tommorow is the day we all been waiting...... keep your seat belts on

19.5 today

the push is coming..